Patients who are heterozygous for loss of function mutations in ACVRL1 develop the vascular disorder Hereditary Haemorrhagic Telangiectasia (HHT) type 2 [5]. This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.